Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression

International Journal of Biochemistry and Cell Biology

Volumn 79, Issue , 2016, Pages 249-260

  Wan, Xuechao ^a   Huang, Wenhua ^a   Yang, Shu ^a   Zhang, Yalong ^a   Zhang, Pu ^a   Kong, Zhe ^a   Li, Tao ^b   Wu, Hai ^a   Jing, Fengxiang ^c   Li, Yao ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF PLANNED PARENTHOOD RESEARCH   (China)

^c SHANGHAI INSTITUTE OF MICROSYSTEM AND INFORMATION TECHNOLOGY   (China)

Author keywords

ADT; Androgen receptor; CRPC; microRNA; PI3K signaling

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANDROGEN; CASPASE 3; MICRORNA; MICRORNA 27A; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; MAP2K4 PROTEIN, HUMAN; MIRN27 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CANCER CELL LINE; CANCER GROWTH; CANCER TISSUE; CASTRATION RESISTANT PROSTATE CANCER; CELL CYCLE; CELL CYCLE ARREST; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LNCAP CELL LINE; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION SITE; UPREGULATION; CARCINOGENESIS; CELL MOTION; DISEASE EXACERBATION; DRUG EFFECTS; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE;

ANDROGENS; APOPTOSIS; BASE SEQUENCE; CARCINOGENESIS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; DOWN-REGULATION; HUMANS; MALE; MAP KINASE KINASE 4; MICRORNAS; PHOSPHATIDYLINOSITOL 3-KINASES; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;

EID: 84984926970     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2016.08.043     Document Type: Article

References (35)

1. Bao, Y., Chen, Z., Guo, Y., Feng, Y., Li, Z., Han, W., Wang, J., Zhao, W., Jiao, Y., Li, K., Wang, Q., Wang, J., Zhang, H., Wang, L., Yang, W., Tumor suppressor microRNA-27a in colorectal carcinogenesis and progression by targeting SGPP1 and Smad2. PLoS One, 9(8), 2014, e105991.
2. Carver, B.S., Chapinski, C., Wongvipat, J., Hieronymus, H., Chen, Y., Chandarlapaty, S., Arora, V.K., Le, C., Koutcher, J., Scher, H., Scardino, P.T., Rosen, N., Sawyers, C.L., Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. Cancer Cell 19:5 (2011), 575–586.
3. Casanova-Salas, I., Rubio-Briones, J., Calatrava, A., Mancarella, C., Masia, E., Casanova, J., Fernandez-Serra, A., Rubio, L., Ramirez-Backhaus, M., Arminan, A., Dominguez-Escrig, J., Martinez, F., Garcia-Casado, Z., Scotlandi, K., Vicent, M.J., Lopez-Guerrero, J.A., Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy. J. Urol. 192:1 (2014), 252–259.
4. Chintharlapalli, S., Papineni, S., Abdelrahim, M., Abudayyeh, A., Jutooru, I., Chadalapaka, G., Wu, F., Mertens-Talcott, S., Vanderlaag, K., Cho, S.D., Smith, R. 3rd, Safe, S., Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells. Int. J. Cancer 125:8 (2009), 1965–1974.
5. Creagh, E.M., Caspase crosstalk: integration of apoptotic and innate immune signalling pathways. Trends Immunol. 35:12 (2014), 631–640.
6. Devlin, H.L., Mudryj, M., Progression of prostate cancer: multiple pathways to androgen independence. Cancer Lett. 274:2 (2009), 177–186.
7. Dweep, H., Sticht, C., Pandey, P., Gretz, N., miRWalk–database: prediction of possible miRNA binding sites by walking the genes of three genomes. J. Biomed. Inform. 44:5 (2011), 839–847.
8. Edlind, M.P., Hsieh, A.C., PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance. Asian J. Androl. 16:3 (2014), 378–386.
9. Fabian, M.R., Sonenberg, N., Filipowicz, W., Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 79 (2010), 351–379.
10. Fletcher, C.E., Dart, D.A., Sita-Lumsden, A., Cheng, H., Rennie, P.S., Bevan, C.L., Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer. Hum. Mol. Genet. 21:14 (2012), 3112–3127.
11. Heinlein, C.A., Chang, C., Androgen receptor in prostate cancer. Endocr. Rev. 25:2 (2004), 276–308.
12. Huang, S., He, X., Ding, J., Liang, L., Zhao, Y., Zhang, Z., Yao, X., Pan, Z., Zhang, P., Li, J., Wan, D., Gu, J., Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int. J. Cancer 123:4 (2008), 972–978.
13. Lewis, B.P., Burge, C.B., Bartel, D.P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:1 (2005), 15–20.
14. Li, J., Wang, Y., Song, Y., Fu, Z., Yu, W., miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells. Mol. Cancer, 13, 2014, 193.
15. Ma, Y., Yu, S., Zhao, W., Lu, Z., Chen, J., miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Lett. 298:2 (2010), 150–158.
16. Min, S., Li, L., Zhang, M., Zhang, Y., Liang, X., Xie, Y., He, Q., Li, Y., Sun, J., Liu, Q., Jiang, X., Zhang, Y., Che, Y., Yang, R., TGF-beta-associated miR-27a inhibits dendritic cell-mediated differentiation of Th1 and Th17 cells by TAB3, p38 MAPK, MAP2K4 and MAP2K7. Genes Immunol. 13:8 (2012), 621–631.
17. Mo, W., Zhang, J., Li, X., Meng, D., Gao, Y., Yang, S., Wan, X., Zhou, C., Guo, F., Huang, Y., Amente, S., Avvedimento, E.V., Xie, Y., Li, Y., Identification of novel AR-targeted microRNAs mediating androgen signalling through critical pathways to regulate cell viability in prostate cancer. PLoS One, 8(2), 2013, e56592.
18. Nadal-Ribelles, M., Solé, C., Xu, Z., Steinmetz, Lars M., de Nadal, E., Posas, F., Control of cdc28 CDK1 by a stress-induced lncRNA. Mol. Cell 53:4 (2014), 549–561.
19. Pan, W., Wang, H., Jianwei, R., Ye, Z., MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells. Cell. Physiol. Biochem. 33:2 (2014), 402–412.
20. Pavese, J.M., Ogden, I.M., Voll, E.A., Huang, X., Xu, L., Jovanovic, B., Bergan, R.C., Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis. PLoS One, 9(7), 2014, e102289.
21. Russell, P.J., Kingsley, E.A., Human prostate cancer cell lines. Methods Mol. Med. 81 (2003), 21–39.
22. Scheibner, K.A., Teaboldt, B., Hauer, M.C., Chen, X., Cherukuri, S., Guo, Y., Kelley, S.M., Liu, Z., Baer, M.R., Heimfeld, S., Civin, C.I., MiR-27a functions as a tumor suppressor in acute leukemia by regulating 14-3-3theta. PLoS One, 7(12), 2012, e50895.
23. Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2015. CA: Cancer J. Clin. 65:1 (2015), 5–29.
24. Singhal, R., Bard, J.E., Nowak, N.J., Buck, M.J., Kandel, E.S., FOXO1 regulates expression of a microRNA cluster on X chromosome. Aging (Milano) 5:5 (2013), 347–356.
25. Taylor, B.S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B.S., Arora, V.K., Kaushik, P., Cerami, E., Reva, B., Antipin, Y., Mitsiades, N., Landers, T., Dolgalev, I., Major, J.E., Wilson, M., Socci, N.D., Lash, A.E., Heguy, A., Eastham, J.A., Scher, H.I., Reuter, V.E., Scardino, P.T., Sander, C., Sawyers, C.L., Gerald, W.L., Integrative genomic profiling of human prostate cancer. Cancer Cell 18:1 (2010), 11–22.
26. Tomczak, K., Czerwinska, P., Wiznerowicz, M., The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp. Oncol. 19:1A (2015), A68–77.
27. Vander Griend, D.J., Kocherginsky, M., Hickson, J.A., Stadler, W.M., Lin, A., Rinker-Schaeffer, C.W., Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7. Cancer Res. 65:23 (2005), 10984–10991.
28. Wagner, E.F., Nebreda, A.R., Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9:8 (2009), 537–549.
29. Wang, L., Pan, Y., Dai, J.L., Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors. Oncogene 23:35 (2004), 5978–5985.
30. Wang, Q., Li, W., Zhang, Y., Yuan, X., Xu, K., Yu, J., Chen, Z., Beroukhim, R., Wang, H., Lupien, M., Wu, T., Regan, M.M., Meyer, C.A., Carroll, J.S., Manrai, A.K., Janne, O.A., Balk, S.P., Mehra, R., Han, B., Chinnaiyan, A.M., Rubin, M.A., True, L., Fiorentino, M., Fiore, C., Loda, M., Kantoff, P.W., Liu, X.S., Brown, M., Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 138:2 (2009), 245–256.
31. Wu, G.S., Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer. Cancer Metastasis Rev. 26:3–4 (2007), 579–585.
32. Xu, L., Ding, Y., Catalona, W.J., Yang, X.J., Anderson, W.F., Jovanovic, B., Wellman, K., Killmer, J., Huang, X., Scheidt, K.A., Montgomery, R.B., Bergan, R.C., MEK4 function, genistein treatment, and invasion of human prostate cancer cells. J. Natl. Cancer Inst. 101:16 (2009), 1141–1155.
33. Yang, J.H., Li, J.H., Shao, P., Zhou, H., Chen, Y.Q., Qu, L.H., starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res. 39 (2011), D202–D209 (Database issue).
34. Yang, S., Zhang, J., Zhang, Y., Wan, X., Zhang, C., Huang, X., Huang, W., Pu, H., Pei, C., Wu, H., Huang, Y., Huang, S., Li, Y., KDM1A triggers androgen-induced miRNA transcription via H3K4me2 demethylation and DNA oxidation. Prostate 75:9 (2015), 936–946.
35. Zhu, L., Wang, Z., Fan, Q., Wang, R., Sun, Y., microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS. Oncol. Rep. 31:1 (2014), 280–286.